Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Director departure
Appointed director
LIBERATOR MEDICAL HOLDINGS, INC. (LBMH) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/21/2016 8-K Quarterly results
01/07/2016 8-K Other Events, Financial Statements and Exhibits
Docs: "ISS and Glass Lewis Recommend that Liberator Medical Shareholders Vote “FOR” Merger Agreement with C. R. Bard, Inc. STUART, Fla., January 7, 2016 -- Liberator Medical Holdings, Inc. announced today that two leading proxy-advisory firms have recommended that Liberator's shareholders vote “FOR” the approval of the merger agreement with C. R. Bard, Inc. at the special meeting of the shareholders being held on January 20, 2016. In its January 5, 2016 report, Institutional Shareholder Services Inc. , a leading independent proxy voting and corporate governance advisory firm stated: “A vote FOR this proposal is warranted given the one-day and two-month premium of 25.9 percent and 28.8 percent, respectively, the robust sales process conducted by [Liberator], and the certainty of value offered by ..."
12/22/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Liberator Medical Announces Definitive Settlement of Qui Tam Litigation",
"Settlement Agreement, entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS), Liberator Medical Supply, Inc., and relators Kimberly Herman, Amy Lestage, and Kevin Roseff, through their authorized representatives"
12/14/2015 8-K Quarterly results
Docs: "FY 2015 FY 2014 Change Net Sales $ 81,602 $ 74,569 9.4% Operating income 11,947 12,709 -6.0% Net income 7,308 7,802 -6.3% Earnings per diluted share 0.14 0.15 -6.7% Dividends declared per share $ 0.13 $ 0.12 8.3% Net sales for fiscal year 2015 increased by $7,033,000, or 9.4%, to $81,602,000, compared with sales of $74,569,000 for fiscal year 2014. The increase in sales was primarily due to the Company's continued emphasis on its direct response advertising campaign to acquire new customers and the Company's emphasis on customer service to maximize the reorder rates for its recurring customer base. Income from operations for fiscal year 2015 decreased by $762,000, or 6.0%, to $11,947,000, compared with fiscal year 2014. The decrease in operating income was primarily attributed to increases..."
11/20/2015 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc. and Freedom MergerSub, Inc",
"Voting and Support Agreement, by and among C. R. Bard, Inc., Mark A. Libratore and Robert Davis",
"Non-Competition Agreement, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc., Freedom MergerSub, Inc. and Mark A. Libratore",
"Consultancy and Non-Competition Agreement, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc., Freedom MergerSub, Inc. and Robert Davis",
"Non-Competition Agreement, by and among Liberator Medical Holdings, Inc., C. R. Bard, Inc., Freedom MergerSub, Inc. and John Léger",
"Liberator Medical Holdings to be Acquired by C. R. Bard for Approximately $181 Million STUART, FLORIDA——November 20, 2015—Liberator Medical Holdings, Inc. , a leading national direct-to-consumer provider of quality medical supplies through its subsidiary, Liberator Medical Supply, Inc., today announced that it has entered into a definitive agreement to be acquired by C. R. Bard, Inc. , for a cash purchase price of $3.35 per fully-diluted share, or approximately $181 million in the aggregate. The purchase price represents a 36% premium over Liberator's average closing price during the 90 trading days ended November 19, 2015. The transaction is expected to close in the first quarter of 2016, subject to approval by Liberator's shareholders, satisfaction of customary closing conditions and rec..."
09/11/2015 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Remarks of President and Chief Executive at the Company's Annual Stockholders Meeting on September 11, 2015"
08/26/2015 8-K Financial Statements and Exhibits
Docs: "Liberator Medical Declares Cash Dividend of $0.0325 per Share This Is the 11th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on September 25, 2015 STUART, FL -- -- 08/25/15 -- Liberator Medical Holdings, Inc. today announced that on August 25, 2015, its Board of Directors approved a cash dividend of $0.0325 per common share to its shareholders. The dividend will be paid on October 9, 2015, to all shareholders of record as of the close of business on September 25, 2015. This is the eleventh consecutive quarterly cash dividend to be paid by the Company, commencing with the dividend paid in May 2013. The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a qua..."
08/11/2015 8-K Quarterly results
Docs: "Liberator Medical Reports Revenue of $20.4 Million and Net Income of $1.7 Million, or $0.03 per Share, for the Three Months Ended June 30, 2015 The Company Reports Revenue Growth of 9.7% for the Three Months Ended June 30, 2015, Compared to the Same Period in 2014"
06/01/2015 8-K Financial Statements and Exhibits
Docs: "Liberator Medical Declares Cash Dividend of $0.0325 per Share This is the 10th Consecutive Quarterly Cash Dividend and is to be Paid to Shareholders of Record at the Close of Business on June 26, 2015 STUART, FL -- -- 05/29/15 -- Liberator Medical Holdings, Inc. today announced that on May 29, 2015, its Board of Directors approved a cash dividend of $0.0325 per common share to its shareholders. The dividend will be paid on July 10, 2015, to all shareholders of record as of the close of business on June 26, 2015. This is the tenth consecutive quarterly cash dividend to be paid by the Company, commencing with the dividend paid in May 2013. The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a quarterly basis the a..."
05/12/2015 8-K Quarterly results
Docs: "Three Months Ended March 31 Six Months Ended March 31"
02/24/2015 8-K Financial Statements and Exhibits
Docs: "This Is the 9th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on March 26, 2015 STUART, FL -- -- 02/24/15 -- Liberator Medical Holdings, Inc. today announced that on February 23, 2015, its Board of Directors approved a cash dividend of $0.0325 per common share to its shareholders. The dividend will be paid on April 10, 2015, to all shareholders of record as of the close of business on March 26, 2015. This is the ninth consecutive quarterly cash dividend to be paid by the Company, commencing with the dividend paid in May 2013. The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors evaluates on a quarterly basis the amount and timing of future dividends based on the Compa..."
02/11/2015 8-K Quarterly results
Docs: "Condensed Consolidated Statements of Operations For the three months ended December 31, 2014 and 2013"
01/12/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation materials provided on January 12, 2015"
12/16/2014 8-K Quarterly results
Docs: "FY 2014 FY 2013 Change Net Sales $ 74,569 $ 69,111 7.9% Operating income 12,709 11,759 8.1% Net income 7,802 7,078 10.2% Earnings per diluted share 0.15 0.14 7.1% Dividends declared per share $ 0.12 $ 0.08 50% Net sales for fiscal year 2014 increased by $5,458,000, or 7.9%, to $74,569,000, compared with sales of $69,111,000 for fiscal year 2013. The increase in sales was primarily due to our continued emphasis on our direct response advertising campaign to acquire new customers and our emphasis on customer service to maximize the reorder rates for our recurring customer base. Income from operations for fiscal year 2014 increased by $950,000, or 8.1%, to $12,709,000, compared with fiscal year 2013. The increase in operating income was primarily attributed to increased gross profits driven b..."
11/24/2014 8-K Financial Statements and Exhibits
Docs: "Liberator Medical Declares Cash Dividend of $0.0325 per Share This Is the 8th Consecutive Quarterly Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on December 26, 2014"
11/03/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Company Expands Number of Board Members From Three to Five STUART, FL -- -- 10/31/14 -- Liberator Medical Holdings, Inc. today announced that its Board of Directors has appointed two new members, Ruben Jose King-Shaw, Jr., and Philip M. Sprinkle. The appointments increase the number of Liberator's directors from three to five. "Phil and Ruben bring tremendous healthcare experience and leadership to our Board of Directors," said Mark Libratore, the Company's President and Chief Executive Officer, and Chairman of the Board. "I am confident that they will make great contributions to our Board and our management team as we continue to build value for our shareholders." "We believe that in today's healthcare environment it is an important benefit to all of us at Liberator to be able to get advi..."
10/20/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Remarks of President and Chief Executive at the Company's Annual"
08/21/2014 8-K Financial Statements and Exhibits
Docs: "Liberator Medical Declares Cash Dividend of $0.0325 per Share, an Increase of $0.0025 or 8.3%"
08/15/2014 8-K Quarterly results
Docs: "Three Months Ended June 30 Nine Months Ended June 30"
06/26/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation materials posted on June 26, 2014"
06/18/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Liberator Medical Set to Join the Russell Global, Russell 3000 and Russell Microcap Indexes on June 27, According to a Preliminary List Posted on June 13"
06/03/2014 8-K Financial Statements and Exhibits
Docs: "Liberator Medical Declares Cash Dividend of $0.03 per Share This Is the 6th Consecutive Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on June 26, 2014"
05/16/2014 8-K Quarterly results
Docs: "Liberator Medical Holdings, Inc. and Subsidiaries Condensed Consolidated Balance Sheets As of March 31, 2014 and September 30, 2013 March 31, September 30, 2014 2013 Assets Current Assets: Cash $ 9,573 $ 12,453 Accounts receivable, net of allowances of $4,659 and $4,502, respectively 9,147 7,836 Inventory, net of allowance for obsolete inventory of $327 and $308, respectively 2,346 2,187 Prepaid income taxes 944 — Deferred tax assets 2,131 2,067 Prepaid and other current assets 521 219 Total Current Assets 24,662 24,762 Property and equipment, net of accumulated depreciation of $3,776 and $3,492, respectively 845 1,044 Deferred advertising, net 25,070 22,705 Intangible assets, net of accumulated amortization of $223 and $169, respectively 478 414 Other assets 178 174 Total Assets $ 51,233 ..."
02/14/2014 8-K Quarterly results
Docs: "Q1 FY2014 Q1 FY2013 Change Net sales $ 18,637 $ 17,551 6.2% Gross profit 11,755 10,978 7.1% Operating income 3,500 2,258 55.0% Net income $ 2,120 $ 1,352 56.8% Net sales for the three months ended December 31, 2013, increased by $1,086,000, or 6.2%, to $18,637,000, compared with net sales of $17,551,000 for the three months ended December 31, 2012. The increase in net sales was due to our continued emphasis on our direct response advertising campaign to acquire new customers and on customer service to maximize the reorder rates for our recurring customer base. Gross profit for the three months ended December 31, 2013, increased by $777,000, or 7.1%, to $11,755,000, compared with gross profit of $10,978,000 for the three months ended December 31, 2012. The increase is attributed to increase..."
02/04/2014 8-K Financial Statements and Exhibits
Docs: "Liberator Medical Declares Cash Dividend of $0.03 per Share"
01/22/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Liberator Medical Holdings States it Knows of No Events That Could Have Caused Unusual Market Activity"
12/26/2013 8-K Quarterly results
Docs: "FY 2013 FY 2012"
11/19/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Liberator Medical Announces That Its Common Stock Has Been Approved for Listing on the NYSE MKT as of November 20, 2013"
11/14/2013 8-K Financial Statements and Exhibits
Docs: "This Is the 4th Consecutive Cash Dividend and Is to Be Paid to Shareholders of Record at the Close of Business on December 26, 2013"
10/28/2013 8-K Form 8-K - Current report
09/03/2013 8-K Form 8-K - Current report
08/09/2013 8-K Quarterly results
Docs: "The Company Reports Net Income of $2.0 Million, or $0.04 per Share, for the Quarter STUART, FL -- -- 08/09/13 -- Liberator Medical Holdings, Inc. today announced the financial results for its fiscal third quarter ended June 30, 2013. Sales for the three months ended June 30, 2013 increased by $2,530,000, or 16.9%, to $17,491,000, compared with sales of $14,961,000 for the three months ended June 30, 2012. For the nine months ended June 30, 2013, sales increased by $7,349,000, or 16.5%, to $51,776,000, compared with sales of $44,427,000 for the nine months ended June 30, 2012. Income from operations for the three months ended June 30, 2013, increased by $2,189,000, or 187.6%, to $3,356,000, compared with the three months ended June 30, 2012. For the nine months ended June 30, 2013, income f..."
07/22/2013 8-K Form 8-K - Current report
06/17/2013 8-K Financial Statements and Exhibits
Docs: "Press release issued by Liberator Medical Holdings, Inc., on June 14, 2013"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy